• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柠檬酸钙与缓释氟化钠联用后的氟生物利用度

Fluoride bioavailability from slow-release sodium fluoride given with calcium citrate.

作者信息

Pak C Y, Sakhaee K, Parcel C, Poindexter J, Adams B, Bahar A, Beckley R

机构信息

Center for Mineral Metabolism and Clinical Research, Southwestern Medical School, University of Texas Southwestern Medical Center, Dallas 75235-8885.

出版信息

J Bone Miner Res. 1990 Aug;5(8):857-62. doi: 10.1002/jbmr.5650050809.

DOI:10.1002/jbmr.5650050809
PMID:2239370
Abstract

Clinical pharmacology of slow-release sodium fluoride given with calcium citrate was examined in acute and long-term studies. Following a single oral administration of 50 mg slow-release sodium fluoride, a peak serum fluoride concentration (Cmax) of 184 ng/ml was reached in 2 h; thereafter, serum fluoride concentration declined with a T1/2 of 5.9 h. The concurrent administration of calcium citrate (400 mg calcium) gave an equivalent Tmax (time required to attain Cmax) and T1/2, but a lower Cmax of 135 ng/ml. The coadministration of a meal with fluoride also reduced Cmax but increased Tmax. The area under the serum concentration curve of slow-release sodium fluoride was reduced 17-27% by a meal or calcium citrate. Thus, calcium citrate reduced fluoride absorption and peak fluoride concentration in serum of slow-release sodium fluoride but did not affect the time required to reach peak concentration or the rate of subsequent decline. The effect of a meal was similar, except for a longer period required to reach peak serum concentration. During long-term administration of 25 mg slow-release sodium fluoride coadministered with 400 mg calcium as calcium citrate on a twice daily schedule, the trough level of serum fluoride could be kept between 95 and 190 ng/ml, believed to be the therapeutic window.

摘要

在急性和长期研究中对与枸橼酸钙合用的缓释氟化钠的临床药理学进行了研究。单次口服50 mg缓释氟化钠后,2小时内血清氟浓度峰值(Cmax)达到184 ng/ml;此后,血清氟浓度以5.9小时的半衰期下降。同时给予枸橼酸钙(400 mg钙)时,达峰时间(达到Cmax所需时间)和半衰期相当,但Cmax较低,为135 ng/ml。氟化物与食物同服也会降低Cmax,但会延长达峰时间。食物或枸橼酸钙使缓释氟化钠的血清浓度曲线下面积减少17 - 27%。因此,枸橼酸钙减少了缓释氟化钠的氟吸收和血清氟峰值浓度,但不影响达到峰值浓度所需的时间或随后下降的速率。食物的影响类似,只是达到血清峰值浓度所需时间更长。在长期每日两次给予25 mg缓释氟化钠与400 mg钙(以枸橼酸钙形式)合用的过程中,血清氟的谷浓度可维持在95至190 ng/ml之间,这被认为是治疗窗。

相似文献

1
Fluoride bioavailability from slow-release sodium fluoride given with calcium citrate.柠檬酸钙与缓释氟化钠联用后的氟生物利用度
J Bone Miner Res. 1990 Aug;5(8):857-62. doi: 10.1002/jbmr.5650050809.
2
Attainment of therapeutic fluoride levels in serum without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis.在绝经后骨质疏松症中使用氟化钠缓释制剂在血清中达到治疗性氟化物水平且无重大副作用。
J Bone Miner Res. 1986 Dec;1(6):563-71. doi: 10.1002/jbmr.5650010611.
3
Fluoride bioavailability from immediate-release sodium fluoride with calcium carbonate compared with slow-release sodium fluoride with calcium citrate.与含柠檬酸钙的缓释氟化钠相比,含碳酸钙的速释氟化钠的氟生物利用度。
Bone Miner. 1991 Aug;14(2):131-6. doi: 10.1016/0169-6009(91)90090-m.
4
Comparative study of fluoride bioavailability following the administration of sodium fluoride alone and in combination with different calcium salts.单独给予氟化钠以及与不同钙盐联合给予后氟生物利用度的比较研究。
J Bone Miner Res. 1990 Mar;5 Suppl 1:S71-3. doi: 10.1002/jbmr.5650051310.
5
Bioequivalence of sodium monofluorophosphate with sodium fluoride and compatibility with calcium.
Arzneimittelforschung. 1990 Sep;40(9):994-9.
6
Relative bioavailability of fluoride from monofluorophosphate tablets after single oral administration.
Arzneimittelforschung. 1990 Mar;40(3):323-8.
7
Effects of meal on the pharmacokinetics of fluoride from oral monofluorophosphate.
Arzneimittelforschung. 1993 May;43(5):590-5.
8
In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.健康志愿者中,来自双峰释放制剂的哌甲酯的体外溶出和体内口服吸收情况。
Biopharm Drug Dispos. 2004 Mar;25(2):91-8. doi: 10.1002/bdd.390.
9
Bioavailability of enteric-coated sodium fluoride tablets as affected by the administration of calcium supplements at different time intervals.不同时间间隔服用钙补充剂对肠溶包衣氟化钠片生物利用度的影响。
J Bone Miner Res. 1990 Mar;5 Suppl 1:S75-9. doi: 10.1002/jbmr.5650051311.
10
Bioavailability and pharmacokinetics of fluoride from two glutamine monofluorophosphate preparations.两种谷氨酰胺单氟磷酸制剂中氟的生物利用度和药代动力学
Arzneimittelforschung. 1993 May;43(5):584-90.

引用本文的文献

1
Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D.骨与克罗恩病:在钙和维生素 D 的基础上添加氟化钠或伊班膦酸盐并无获益。
World J Gastroenterol. 2011 Jan 21;17(3):334-42. doi: 10.3748/wjg.v17.i3.334.
2
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis.静脉注射帕米膦酸盐与帕米膦酸盐加缓释氟化钠治疗绝经后骨质疏松症的三年疗效
Osteoporos Int. 2003 Jul;14(6):500-6. doi: 10.1007/s00198-003-1397-0. Epub 2003 May 15.
3
Comparison of serum fluoride levels after administration of monofluorophosphate-calcium carbonate or sodium fluoride: differences in peak serum concentrations.
单氟磷酸钙-碳酸钙或氟化钠给药后血清氟水平的比较:血清峰值浓度的差异。
Clin Investig. 1994 Dec;72(12):1082-5. doi: 10.1007/BF00577760.